Corbus Pharmaceuticals Announces Broad Alignment with FDA on Registration Path for CRB-701 in Second-Line HNSCC and Cervical Cancer
Go back to Corbus Pharmaceuticals Announces Broad Alignment with FDA on Registration Path for CRB-701 in Second-Line HNSCC and Cervical Cancer| (NASDAQ: CRBP) | Delayed: 8.31 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.31 | 52 Week High | $10.78 | |||
| Open | $8.31 | 52 Week Low | $1.01 | |||
| Day High | $8.31 | P/E | N/A | |||
| Day Low | $8.31 | EPS | $0.00 | |||
| Volume | 1,305 | |||||
